银诺医药-B:认购1.05亿元结构性存款产品

Core Viewpoint - Silver诺医药-B (02591) announced the subscription of a structured deposit product from Ningbo Bank for a total consideration of RMB 105 million, which equals its total principal amount [1] Group 1 - The company, along with its wholly-owned subsidiary Silver诺技术, is engaging in a financial investment through a structured deposit [1] - The total investment amount is RMB 105 million, indicating a significant commitment to this financial product [1]